AplusA 30+ years Anniversary - Interview #1
In ‘21, we are celebrating our 30+.
AplusA is actually 30+ years old this year... But what does it mean to be in business for over 30 years?
AplusA
AplusA Anniversaire 30+ ans - Interview #1
C’est l’année 21, mais nous en célébrons plus de 30.
En 2021, AplusA fête - non pas ses 30 -...
Social Media Insights: ASCO 2020 Part 2
The American Society of Oncologists (ASCO) annual meeting is a major fixture in the global...
Welcoming the new-look AplusA website!
You might have noticed that our site looks a little different. We wanted to share the story...
DLBCL Patient Insights in the US and EU5
When working on a new or existing brand within the DLBCL market it's important to have up to...
Social Media Insights: ASCO 2020 Part 1
The American Society of Oncologists (ASCO) annual meeting is a major fixture in the global...
Social Media Listening: Insights from Healthcare conferences
Market Research Industry, Social Media Listening
Healthcare conferences provide unique opportunities to gain first-hand insights from otherwise...
DLBCL Treatment Performance in EU5 and US
hemato-oncology, Tracking Studies, DLBCL market
The DLBCL market is undergoing a period of change, and the relative performance of the various...
DLBCL Market Overview
hemato-oncology, Tracking Studies, DLBCL market
Following the release of our latest ebook, this is the first blog post in this series focusing...
New AplusA eBook Covers the DLBCL Market
Introducing the latest eBook in AplusA's Hemato-Oncology series